Europe's beating cancer plan : EUCAPA : European Capacity Building for Patients

Typically, a Health Technology Assessment (HTA) measures the added value of a new medicine in comparison with the best existing treatment. Patients have direct knowledge on which side effects are manageable, the impact and most relevant factors, and the qualitative meaning of quality-of-life improvements. EUCAPA will ensure that the HTA Cooperation includes the patient perspective.

MoreLess

Year of publication:	[2024]
Institutions:	European Commission / Directorate-General for Health and Food Safety (issuing body)
Publisher:	[Luxembourg] : [Publications Office]
Subject:	Krebskrankheit \| Cancer \| Europa \| Europe \| Patienten \| Patients \| EU-Staaten \| EU countries \| Gesundheitsversorgung \| Health care

Extent:	1 Online-Ressource ([2] p.) Illustrationen (farbig)
Type of publication:	Book / Working Paper
Language:	English
ISBN:	978-92-68-11758-3
Other identifiers:	10.2875/42365 [DOI]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10015276556